BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20410194)

  • 1. The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats.
    Mochida T; Hira T; Hara H
    Endocrinology; 2010 Jul; 151(7):3095-104. PubMed ID: 20410194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLP-1 secretion is enhanced directly in the ileum but indirectly in the duodenum by a newly identified potent stimulator, zein hydrolysate, in rats.
    Hira T; Mochida T; Miyashita K; Hara H
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G663-71. PubMed ID: 19661152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and Goto-Kakizaki rats.
    Higuchi N; Hira T; Yamada N; Hara H
    Endocrinology; 2013 Sep; 154(9):3089-98. PubMed ID: 23798598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rice protein hydrolysates stimulate GLP-1 secretion, reduce GLP-1 degradation, and lower the glycemic response in rats.
    Ishikawa Y; Hira T; Inoue D; Harada Y; Hashimoto H; Fujii M; Kadowaki M; Hara H
    Food Funct; 2015 Aug; 6(8):2525-34. PubMed ID: 26107658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular fraction of wheat protein hydrolysate stimulates glucagon-like peptide-1 secretion in an enteroendocrine L cell line and improves glucose tolerance in rats.
    Kato M; Nakanishi T; Tani T; Tsuda T
    Nutr Res; 2017 Jan; 37():37-45. PubMed ID: 28215313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition.
    Chang E; Kim L; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park DI; Park CY
    Metabolism; 2015 May; 64(5):633-41. PubMed ID: 25704082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of glycemic control in streptozotocin-induced diabetic rats by Atlantic salmon skin gelatin hydrolysate as the dipeptidyl-peptidase IV inhibitor.
    Hsieh CH; Wang TY; Hung CC; Chen MC; Hsu KC
    Food Funct; 2015 Jun; 6(6):1887-92. PubMed ID: 25946069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLP-1 secretion in response to oral and luminal palatinose (isomaltulose) in rats.
    Hira T; Muramatsu M; Okuno M; Hara H
    J Nutr Sci Vitaminol (Tokyo); 2011; 57(1):30-5. PubMed ID: 21512288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bis-Pyrano Prenyl Isoflavone Improves Glucose Homeostasis by Inhibiting Dipeptidyl Peptidase-4 in Hyperglycemic Rats.
    Altenhofen D; da Luz G; Frederico MJ; Venzke D; Brich M; Vigil S; Fröde TS; Linares CE; Pizzolatti MG; Silva FR
    J Cell Biochem; 2017 Jan; 118(1):92-103. PubMed ID: 27238050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
    Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
    Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive increase in active GLP-1 levels by the DPP4 inhibitor ASP4000 on a new meal tolerance test in Zucker fatty rats.
    Tanaka-Amino K; Hatakeyama Y; Takakura S; Mutoh S
    Pharmacol Res; 2009 Oct; 60(4):264-9. PubMed ID: 19520592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical and pharmacological properties of glucagon-like peptide-1 in rats under isoflurane anesthesia.
    Kawano T; Tanaka K; Chi H; Eguchi S; Yamazaki F; Kitamura S; Kumagai N; Yokoyama M
    Anesth Analg; 2012 Jul; 115(1):62-9. PubMed ID: 22504208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents.
    Oguma T; Nakayama K; Kuriyama C; Matsushita Y; Yoshida K; Hikida K; Obokata N; Tsuda-Tsukimoto M; Saito A; Arakawa K; Ueta K; Shiotani M
    J Pharmacol Exp Ther; 2015 Sep; 354(3):279-89. PubMed ID: 26105952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent effect of glucose on GLP-1 secretion involves sweet taste receptor in isolated perfused rat ileum [Rapid Communication].
    Xu Z; Wang W; Nian X; Song G; Zhang X; Xiao H; Zhu X
    Endocr J; 2016 Dec; 63(12):1141-1147. PubMed ID: 27853059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum.
    Dumoulin V; Moro F; Barcelo A; Dakka T; Cuber JC
    Endocrinology; 1998 Sep; 139(9):3780-6. PubMed ID: 9724030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nondigestible saccharide, fructooligosaccharide, increases the promotive effect of a flavonoid, α-glucosyl-isoquercitrin, on glucagon-like peptide 1 (GLP-1) secretion in rat intestine and enteroendocrine cells.
    Phuwamongkolwiwat P; Hira T; Hara H
    Mol Nutr Food Res; 2014 Jul; 58(7):1581-4. PubMed ID: 24753209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations.
    Fukuda-Tsuru S; Anabuki J; Abe Y; Yoshida K; Ishii S
    Eur J Pharmacol; 2012 Dec; 696(1-3):194-202. PubMed ID: 23022337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between anagliptin concentration showing over 80% inhibition of plasma dipeptidyl peptidase-4 activity and its protective effect against glucagon-like peptide-1 degradation.
    Furuta S; Goto M; Tamura M; Yamashita S; Nakaya K; Furuta Y
    Drug Res (Stuttg); 2014 Mar; 64(3):130-5. PubMed ID: 23965798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats.
    Balkan B; Kwasnik L; Miserendino R; Holst JJ; Li X
    Diabetologia; 1999 Nov; 42(11):1324-31. PubMed ID: 10550416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.